Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The severity of female pattern hair loss is linked to how long someone has had it, not to levels of certain nutrients or hormones.

Primary cicatricial alopecia causes permanent hair loss by destroying hair follicles, and its exact cause is unknown.

Combining microneedling with 5% minoxidil is a safe and effective treatment for female pattern hair loss, promoting significant hair regrowth.

A holistic approach combining homeopathy, Xogen therapy, and lifestyle changes may improve hair loss.

Keratosis pilaris is common in young females, and dermoscopy helps diagnose it accurately.

Bicalutamide may improve hair growth in postmenopausal women with mild side effects.

Baricitinib is effective and safe for treating severe alopecia areata.

FUE technique offers higher satisfaction and broader use for women needing hair transplants.

Single-needle radiofrequency is effective and safe for treating facial sebaceous hyperplasia.

FCER1A and RGS1 may help diagnose and treat systemic lupus erythematosus.

Canine alopecia areata is a chronic condition needing long-term management.

Temporary hair shedding after minoxidil use may indicate effective treatment.

Combining treatments works best for early hair loss, while transplants are best for severe cases.

Myo-inositol with magnesium effectively reduces acne and hirsutism in PCOS patients without side effects.

Low-dose oral minoxidil does not significantly change alcohol consumption.

PRP therapy is more effective and preferred over minoxidil for hair loss.

Telogen effluvium is common after symptomatic COVID-19, especially in young females, and may be linked to nutritional deficiencies.

Baricitinib is effective and safe for treating severe alopecia areata.

Teledermatology effectively diagnoses and manages non-scarring alopecia remotely.

QR678 Neo is more effective than PRP for hair growth and quality.

Systemic minoxidil is generally safe for older adults, but caution is needed for those with heart risks.

Tofacitinib is a promising and safe treatment for moderate to severe alopecia areata.

Blood cell counts could help predict and treat alopecia areata and telogen effluvium.

Generic topical and transdermal systems usually cause minimal irritation or sensitization.

CGF injections may safely and effectively promote hair growth in androgenetic alopecia patients.

Most patients with PCOS were prescribed medroxyprogesterone acetate or oral contraceptives, with some experiencing side effects or needing prescription changes.

DCPA commonly affects males' lower legs, showing follicular pustules and white areas.

Frontal fibrosing alopecia mainly affects women over 50, causing hair loss and specific skin changes.

Blood count parameters are not reliable for predicting recurrent implantation failure.

Hair transplants are better for severe hair loss, while scalp micropigmentation suits those with denser hair.